Table 3.
Infectious Etiology - Consolidation Part 2
| Clofarabine 30 mg/m2/day × 5 | |||
|---|---|---|---|
| Organism Name | Control Arm (N=25) |
Experimental Arm 1 (N=51) |
Experimental Arm 2 (N=52) |
| Gram Positive | 1 | 1 | 8 |
| Streptococcus mitis | 1 | 3 | |
| Coag negative Staphylococcus | 1 | ||
| Staphylococcus aureus | 1 | ||
| Streptococcus viridans | 1 | 1 | |
| Staphylococcus epidermidis | 1 | ||
| Staphylococcus saprophyticus | 1 | ||
| Gram Negative | 0 | 1 | 7 |
| Klebsiella pneumoniae | 3 | ||
| Pseudomonas aeruginosa | 2 | ||
| Escherichia coli | 1 | 2 | |
| Anaerobic | 0 | 0 | 1 |
| Clostridium difficile | 1 | ||
| Fungus | 1 | 0 | 9 |
| Candida tropicalis | 1 | ||
| Blastoschzomyces capitatus | 1 | ||
| Aspergillus | |||
| Aspergillus nos | 1 | 3 | |
| Aspergillus terreus | 1 | ||
| Aspergillus versicolor | 1 | ||
| Aspergillus fumigatus | 1 | ||
| Geotrichum (yeast) | 1 | ||
| Total | 2 | 2 | 25 |